Amicus Therapeutics
FOLD63
$11.65arrow_drop_down0.34%-$0.04
FOLD63
$11.65
arrow_drop_down0.34%AI Deep-Learning Forecast (FOLD)
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Amicus Therapeutics (FOLD) Stocklytics Forecast
Keep an eye on Amicus Therapeutics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the analyst price prediction for Amicus Therapeutics (FOLD) stock?
Analysts have set a target price of $15.86 for Amicus Therapeutics (FOLD), based on forecasts from 22 analysts. The predicted price range extends from a high of $22 to a low of $11. This represents a potential increase of up to 88.84% and a decrease of -5.58% from the current price of $11.65. These forecasts are as of 2021 Mar 02.
help
What are the analyst ratings for Amicus Therapeutics (FOLD) stock?
The analyst ratings for Amicus Therapeutics (FOLD) are distributed as follows: 6 analysts recommend buying, 1 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 7 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Amicus Therapeutics .
help
What is the AI price prediction for Amicus Therapeutics (FOLD) stock?
At present, there is no AI or machine-learning-based price prediction available for Amicus Therapeutics (FOLD) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.